TRAX
First Tracks BiotherapeuticsNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage ready
$31.68-6.96%
Close Oct 13, 2026
- Market cap
- $1.12B
- 1 month
- -15.7%
- 3 months
- -12.3%
- 1 year
- —
- Dividend
- No dividends on record
- Next-quarter EPS estimate
- -$0.89Quarter to Sep 30, 2026 · 10 analysts · revenue $0
- Short interest
- 19.8% of float5.2M shares · settled Sep 30, 2026 · +15.3% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- —
- Net income
- —
- Free cash flow
- —
- Book value
- $168.8M
- Total debt
- $4.33M
- P/E
- —
- Price / sales
- —
- Price / book
- 6.6×
- FCF yield
- —
- Net margin
- —
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if TRAX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: MEDIUM
34 top institutions tracked
as of 2026-Q2 (filed 2026-09-22)
Insider context
Sentiment: neutral
Last trade: sell 40 days ago
Red flags: 9
Largest 13-F holders · Q2 2026
151 filers reported a long position in TRAX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| EcoR1 Capital, LLC | $63.9M | 3.2M | New |
| TCG Crossover Management, LLC | $58.3M | 2.9M | New |
| FMR LLC | $41.3M | 2.1M | New |
| Affinity Asset Advisors, LLC | $40.9M | 2M | New |
| BlackRock, Inc. | $39.5M | 2M | New |
| Trails Edge Capital Partners, LP | $30.5M | 1.5M | New |
| STATE STREET CORP | $30.4M | 1.5M | New |
| VANGUARD CAPITAL MANAGEMENT LLC | $29.2M | 1.5M | New |
| Jupiter Topco LLC | $22M | 1.1M | — |
| Vestal Point Capital, LP | $20.4M | 1M | New |
Get the Full Analysis for TRAX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.